PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients

被引：0
|
作者：
Ming Chen
Jinlian Zhu
Xuedong Yang
Jianxin Yao
Yuqing Liu
Qiang Liu
机构：
[1] Changshu No.2 People’s Hospital,Department of Hematology
[2] Changshu No.2 People’s Hospital,Department of Oncology
[3] Changshu No.1 People’s Hospital,Department of Hematology
来源：
European Journal of Medical Research | / 27卷
关键词：
Relapsed/refractory multiple myeloma; T cell subtype; PD-1; LAG-3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Expression of PD-1/LAG-3 and cytokine production by CD4+ T cells during infection with Plasmodium parasites
    Doe, Henrietta T.
    Kimura, Daisuke
    Miyakoda, Mana
    Kimura, Kazumi
    Akbari, Masoud
    Yui, Katsuyuki
    MICROBIOLOGY AND IMMUNOLOGY, 2016, 60 (02) : 121 - 131
  • [22] Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3+anti-PD-1-based immunotherapies
    Gide, Tuba N.
    Paver, Elizabeth C.
    Yaseen, Zarwa
    Maher, Nigel
    Adegoke, Nurudeen
    Menzies, Alexander M.
    da Silva, Ines Pires
    Wilmott, James S.
    Long, Georgina V.
    Scolyer, Richard A.
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [23] PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacy
    Shi, Ning
    Zhou, Yangyihua
    Liu, Yujun
    Zhang, Ran
    Jiang, Xingjun
    Ren, Caiping
    Gao, Xiang
    Luo, Longlong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] LAG-3+tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+tumors
    Burugu, S.
    Gao, D.
    Leung, S.
    Chia, S. K.
    Nielsen, T. O.
    ANNALS OF ONCOLOGY, 2017, 28 (12) : 2977 - 2984
  • [25] Effect of Daratumumab combined with Chemotherapy on Immune Function in Patients with Relapsed/Refractory Multiple Myeloma and Observation of its Clinical Efficacy
    Zhang, Ye-hua
    Xu, Feng
    Xu, Chang-qing
    Zhang, Zi-tan
    Jiao, Zong-jiu
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (01)
  • [26] Serum Concentrations of TIM-3, LAG-3, and PD-1 in Patients with Hemorrhagic Fever with Renal Syndrome
    Safranko, Zeljka Macak
    Jakopec, Lana
    Svagusa, Karla
    Krajinovic, Lidija Cvetko
    Tomasovic, Domagoj
    Lukic, Ljiljana
    Markotic, Alemka
    LIFE-BASEL, 2024, 14 (05):
  • [27] PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma
    Zhong, Yu-Min
    Yin, Kai
    Chen, Yu
    Xie, Zhi
    Lv, Zhi-Yi
    Yang, Jin-Ji
    Yang, Xue-Ning
    Zhou, Qing
    Wang, Bin-Chao
    Zhong, Wen-Zhao
    Gao, Ling-Ling
    Zhou, Wen-Bin
    Chen, Ji
    Tu, Hai-Yan
    Liao, Ri-Qiang
    Zhang, Dong-Kun
    Zhang, Shui-Lian
    Lu, Dan-Xia
    Zheng, Hong-Bo
    Zhang, Heng-Hui
    Wu, Yi-Long
    Zhang, Xu-Chao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] PD-1 and LAG-3 expression in EBV-associated pediatric Hodgkin lymphoma has influence on survival
    Jimenez, Oscar
    Mangiaterra, Tamara
    Colli, Sandra
    Garcia Lombardi, Mercedes
    Victoria Preciado, Maria
    De Matteo, Elena
    Chabay, Paola
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Expression of PD-1, LAG-3 and CD39 in Peripheral Blood CD4+CD25+Foxp3+T Cells of Patients with Gastric Malignant Tumor
    Chen, Jizhong
    Zhang, Sheng
    Yuan, Yuan
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (06) : 3085 - 3093
  • [30] Patient-Reported Outcomes in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) Treated With Belantamab Mafodotin (Belamaf) Versus Pomalidomide Plus Low-Dose Dexamethasone (Pd) in the DREAMM-3 Study
    Hungria, Vania
    Weisel, Katja
    Currie, Brooke
    Perera, Sue
    Sule, Neal
    He, Wei
    Davy, Katherine
    McKeown, Astrid
    Sapra, Sandhya
    Nelsen, Linda
    Li, Mary
    Barale, Sophie
    Boyle, Julia
    McPoyle, Kaytlyn
    Dimopoulos, Meletios Athanasios
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S505 - S505
12345